ZBNA
MIRM icon

Zions Bancorporation, National Association’s Mirum Pharmaceuticals MIRM Stock Holding History

Zions Bancorporation, National Association’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.93K Buy
25
+1
+4% +$100 ﹤0.01% 1215
2026
Q1 		$2.22K Buy
+24
New +$2.26K ﹤0.01% 1187

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Zions Bancorporation, National Association's MIRM Position: Q2 2026 in Review

Zions Bancorporation, National Association increased its Mirum Pharmaceuticals (MIRM) stake by 4.2% in Q2 2026, buying an estimated $100 and bringing the position to 25 shares worth $2.93K. The position accounts for ﹤0.01% of the portfolio, ranked #1215.

Zions Bancorporation, National Association first reported a position in MIRM in Q1 2026 and has held it in 2 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Zions Bancorporation, National Association held 25 shares of Mirum Pharmaceuticals worth $2.93K as of Q2 2026.
  • Zions Bancorporation, National Association bought 1 Mirum Pharmaceuticals share in Q2 2026, an estimated $100.
  • Mirum Pharmaceuticals made up ﹤0.01% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #1215 holding.
  • Zions Bancorporation, National Association first reported a position in Mirum Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.